Quick Answer
Cytosorbents Corp reported Total Assets of $44.18 million for the year ending 2025.
- Cytosorbents Corp showed a decrease of -6.7% in Total Assets from 2024 to 2025.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $3.86 million | Q3 2011: $2.93 million | Q1 2012: $2.78 million | Q2 2012: $2.90 million | Q3 2012: $3.27 million | Q1 2013: $2.53 million | Q2 2013: $2.98 million | Q3 2013: $4.04 million | Q1 2014: $12.39 million | Q2 2014: $11.26 million | Q3 2014: $9.63 million | Q1 2015: $15.86 million | Q2 2015: $14.10 million | Q3 2015: $12.80 million | Q1 2016: $9.51 million | Q2 2016: $12.71 million | Q3 2016: $10.86 million | Q1 2017: $8.29 million | Q2 2017: $22.09 million | Q3 2017: $22.22 million | Q1 2018: $28.30 million | Q2 2018: $34.95 million | Q3 2018: $34.25 million | Q1 2019: $30.99 million | Q2 2019: $28.48 million | Q3 2019: $28.68 million | Q1 2020: $44.23 million | Q2 2020: $49.26 million | Q3 2020: $104.28 million | Q1 2021: $87.48 million | Q2 2021: $98.19 million | Q3 2021: $95.07 million | Q1 2022: $83.27 million | Q2 2022: $71.21 million | Q3 2022: $62.27 million | Q1 2025: $50.78 million | Q2 2025: $47.99 million | Q3 2025: $45.75 million.
- Over the full 22 years of available data (2010 to 2025), Cytosorbents Corp's Total Assets has grown by 2,338.4%.
- Historical annual values: Fiscal year 2025: $44.18 million | Fiscal year 2024: $47.37 million | Fiscal year 2024: $47.80 million | Fiscal year 2024: $53.43 million | Fiscal year 2024: $47.07 million | Fiscal year 2023: $52.96 million | Fiscal year 2023: $47.58 million | Fiscal year 2023: $52.44 million | Fiscal year 2023: $57.46 million | Fiscal year 2022: $63.23 million | Fiscal year 2021: $89.52 million | Fiscal year 2020: $89.95 million | Fiscal year 2019: $27.38 million | Fiscal year 2018: $34.20 million | Fiscal year 2017: $24.10 million | Fiscal year 2016: $9.69 million | Fiscal year 2015: $11.25 million | Fiscal year 2014: $8.47 million | Fiscal year 2013: $4.05 million | Fiscal year 2012: $3.34 million | Fiscal year 2011: $2.12 million | Fiscal year 2010: $1.81 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: